Bambu Ventures and Innova Capital Partners Form SPV to Acquire Lemonaid Health
September 16, 2025
Chrome Holding Co. (formerly operating as 23andMe Holding Co.) entered into a stock purchase agreement under which an SPV formed by Bambu Ventures and Innova Capital Partners will acquire 100% of Lemonaid Health, Inc. and Lemonaid Pharmacy Holdings, Inc. pending approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.
- Buyers
- Bambu Ventures, Innova Capital Partners, Chrome Holding Co.
- Targets
- Lemonaid Health, Inc., Lemonaid Pharmacy Holdings, Inc.
- Sellers
- Chrome Holding Co. (formerly operating as "23andMe Holding Co.")
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
23andMe Acquires Lemonaid Health
October 22, 2021
Healthcare Services
23andMe agreed to acquire telemedicine and online pharmacy provider Lemonaid Health for a purchase price of $400 million (25% cash, 75% stock), in a deal expected to close by the end of 2021. The acquisition adds Lemonaid's telemedicine platform and prescription delivery services to 23andMe's consumer business; Lemonaid CEO Paul Johnson will become General Manager of 23andMe's consumer business.
-
WebMD Health Services Acquires Limeade
June 8, 2023
Healthcare Services
WebMD Health Services, a unit of WebMD Health Corp., announced it will acquire Limeade, an employee well‑being platform provider. The deal combines WebMD Health Services’ clinical and program capabilities with Limeade’s digital engagement technology to create a more comprehensive, holistic workplace well‑being offering; the transaction is expected to close within the next quarter pending approvals.
-
The Real Brokerage Inc. to Acquire LemonBrew Lending
September 26, 2022
Cloud & SaaS
The Real Brokerage Inc. signed an agreement to acquire LemonBrew Lending Corp., a tech-enabled home loan platform operating as a mortgage brokerage and licensed lender across 20 U.S. states. The deal is structured as a share purchase agreement for total consideration of $1.25 million ($800,000 in cash plus $450,000 in Real shares), with completion expected in the fourth quarter of 2022.
-
HLM Leads $16M Growth Investment in HPS/PayMedix; $33M Financing Raised
January 13, 2026
Healthcare Services
HPS/PayMedix closed $33 million of equity and debt financing to accelerate national growth of its healthcare financing and payments platform. The round was led by HLM Investment Partners ($16M growth equity) and included Escalate Capital Partners (providing a $17M term debt facility), RVM Enterprises, and existing investor SV Health Investors.
-
Lomond Therapeutics Completes Reverse Merger with Venetian-1 and Raises $44M
November 4, 2024
Biotechnology
Lomond Therapeutics completed a reverse merger with Venetian-1 Acquisition Corp., which changed its name to Lomond Therapeutics Holdings, Inc., and closed a $44 million private placement led by existing and new investors. The financing included participation from OrbiMed, Torrey Pines Investment, Deerfield Management, American Financial Group and Heights Capital and will fund advancement of Lomond’s clinical-stage oncology programs (lomonitinib, lonitoclax and a menin inhibitor).
-
Stripe Acquires Lemon Squeezy
July 26, 2024
Payments & Fintech
Stripe has acquired Lemon Squeezy, a four-year-old payments and merchant-of-record platform that serves SaaS and digital-product businesses. Terms were not disclosed; Lemon Squeezy — a ~13-person startup that surpassed $1M ARR within nine months of launch — will help Stripe scale merchant-of-record selling and related billing/tax capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.